CW-301 FIH Study of CAN016

Clinical trial NCT07664150 · RECRUITING

Trial details

NCT number: NCT07664150
Sponsor: Canwell Biotech Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors

Start date: 2026-06-18
Primary completion: 2028-12-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.